G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $595,898 | +2028.2% | 109,339 | +9777.1% | 0.00% | – |
Q1 2021 | $28,000 | -71.7% | 1,107 | -79.1% | 0.00% | – |
Q4 2020 | $99,000 | +421.1% | 5,285 | +235.8% | 0.00% | – |
Q3 2020 | $19,000 | -67.2% | 1,574 | -42.2% | 0.00% | – |
Q2 2020 | $58,000 | -48.7% | 2,722 | -36.2% | 0.00% | – |
Q4 2019 | $113,000 | +66.2% | 4,264 | +43.7% | 0.00% | – |
Q3 2019 | $68,000 | -20.9% | 2,968 | +5.6% | 0.00% | – |
Q2 2019 | $86,000 | – | 2,811 | +93600.0% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 3 | -99.1% | 0.00% | – |
Q4 2018 | $6,000 | -25.0% | 321 | +122.9% | 0.00% | – |
Q3 2018 | $8,000 | +33.3% | 144 | -0.7% | 0.00% | – |
Q2 2018 | $6,000 | – | 145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |